Company: MBIO
Filing Date: 2025-02-07
Form Type: 424B4
Source: 0001410578-25-000085
Chunk: 89

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-07
Form: 424B4
Chunk 89
---
        ​ | ​ |
| Preferred Stock ($0.0001 par value), 2,000,000 shares authorized, 250,000 shares of Class A Preferred Stock issued and outstanding Class A Preferred Stock | ​ | ​                  |        — | ​ | ​         |        — | ​ | ​            |        — | ​ |
| Common Stock ($0.0001 par value), 200,000,000 shares authorized Class A Common shares                                                                      | ​ | ​                  |        — | ​ | ​         |        — | ​ | ​            |        — | ​ |
| Common shares                                                                                                                                              | ​ | ​                  |        3 | ​ | ​         |        3 | ​ | ​            |        3 | ​ |
| Additional paid-in capital                                                                                                                                 | ​ | ​                  |  387,112 | ​ | ​         |  392,719 | ​ | ​            |  399,635 | ​ |
| Accumulated deficit                                                                                                                                        | ​ | ​                  | -395,771 | ​ | ​         | -395,771 | ​ | ​            | -395,771 | ​ |
| Total Stockholders’ Equity (Deficit)                                                                                                                       | ​ | ​                  |   -8,656 | ​ | ​         |   -3,049 | ​ | ​            |    3,867 | ​ |
| Total Capitalization                                                                                                                                       | ​ | $                  |   -8,656 | ​ | $         |   -3,049 | ​ | $            |    3,867 | ​ |

The foregoing discussion and tables above are based on 735,996 shares of common stock outstanding as of September 30, 2024, and excludes:

| ● | 1,521 shares of our common stock issuable upon the exercise of outstanding stock options as of September 30, 2024, with a weighted-average exercise price of $4,297.50 per share; |

| ● | 1,219,116 shares of our common stock issuable upon the exercise of outstanding warrants as of September 30, 2024, with a weighted-average exercise price of $14.39 per share; |

| ● | 1,127 shares of our common stock issuable upon conversion of the Class A Common Stock, at the holders’ election; |

| ● | 333 shares of our common stock issuable upon conversion of the Class A Preferred Stock, at the holders’ election; |

57